The Ensign Group Inc – Medical Stock For 2021
The Ensign Group provides a range of skilled nursing and assisted living services as well as other post-acute healthcare services. The company does business in 13 US states in the South, West, and Mid-West regions. The slowing down of COVID in the US had led to a rise in the demand for healthcare services that Ensign offers. An aging US population is another long-term trend that boosts the future growth prospects of The Ensign Group. So, if you are looking for medical care facilities stocks, then consider exploring businesses with a portfolio of owned and leased facilities. The Ensign Group is one such company and it specializes in the operation and management of nursing and senior living facilities. As an investor keenly interested in the healthcare space, it may be a good idea to stay in touch with the growing field of assisted living and nursing.
Business Information About The Ensign Group
The Ensign Group was founded as recently as 1999, just before the new millennium. As mentioned above, the Ensign Group follows a relatively asset-light approach by leasing some of the facilities in which it operates. Currently, the company operates at a total of 228 facilities. Out of those, 164 are leased on a long-term basis. Out of those 164 facilities, The Ensign Group has an option to purchase 11 facilities. The Ensign Group has leased 31 senior living facilities to The Pennant Group. The Ensign Group has two reportable business segments. The first one is transitional and skilled services. It deals in rehabilitation services and skilled nursing facilities. The second segment is real estate as The Ensign Group has a fairly sizeable portfolio of facilities as outlined above. Any investor looking for a medical stock for 2021 may consider studying The Ensign Group more closely.
Medical Care Facilities Stocks
You can find the stock for The Ensign Group by looking up ENSG on the Nasdaq stock exchange. The stock last traded at $79.74 on 7th December 2021. It was down a little more than 2% on a 1-month basis. The 1-year return for the stock was around 5.1%.
